Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Urinary Antiseptic Antispasmodic
Overview
What is Me NaPhos MB Hyo 1?
Each tablet contains:
What does Me NaPhos MB Hyo 1 look like?
What are the available doses of Me NaPhos MB Hyo 1?
Sorry No records found.
What should I talk to my health care provider before I take Me NaPhos MB Hyo 1?
Sorry No records found
How should I use Me NaPhos MB Hyo 1?
ME/NaPhos/MB/Hyo 1 Tablets
Adults
Older Children
What interacts with Me NaPhos MB Hyo 1?
Sorry No Records found
What are the warnings of Me NaPhos MB Hyo 1?
Sorry No Records found
What are the precautions of Me NaPhos MB Hyo 1?
Sorry No Records found
What are the side effects of Me NaPhos MB Hyo 1?
Sorry No records found
What should I look out for while using Me NaPhos MB Hyo 1?
Do not exceed recommended dosage. If rapid pulse,
dizziness, or blurring of vision occurs
What might happen if I take too much Me NaPhos MB Hyo 1?
Emesis or gastric lavage. Slow intravenous
administration of physostigmine in doses of 1 mg to
4 mg (0.5 mg to 1 mg in children), repeated as needed
in one to two hours to reverse severe antimuscarinic
symptoms. Administration of small doses of diazepam to
control excitement and seizures. Artificial respiration
with oxygen if needed for respiratory depression.
Adequate hydration. Symptomatic treatment as
necessary.
How should I store and handle Me NaPhos MB Hyo 1?
Store at 25°C (77°F); excursions permitted between 15°C and 30°C (59°F to 86°F) [See USP controlled room temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container.ME/NaPhos/MB/Hyo 1 Tablets are light blue to blue, oval, biconvex tablets debossed with "M455" with scoreline on one side and plain on the other side. Supplied in bottles of 100 tablets (NDC 58657-454-01).
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
HYOSCYAMINE
METHENAMINE
METHYLENE BLU
MONOBASIC SODIUM PHOSPHATE
Non-Clinical Toxicology
Do not exceed recommended dosage. If rapid pulse, dizziness, or blurring of vision occursKnown drug interactions include barbiturates, tranquilizers, and alcohol. Diphenoxylate hydrochloride and atropine sulfate may interact with MAO inhibitors (see ).
In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day. Therefore, diphenoxylate has the potential to prolong the biological half-lives of drugs for which the rate of elimination is dependent on the microsomal drug metabolizing enzyme system.
(Pregnancy Category C) hyoscyamine and methenamine cross the placenta. Studies have not been done in animals or humans. It is not known whether cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. should be given to a pregnant woman only if clearly needed.
Cardiovascula
Central Nervous System
Genitourinary
Gastrointestinal
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).